Legal Cannabis Market, By Source (Marijuana and Hemp), By Derivatives, By End-Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4619
|
Published Date
January 2026
|
Pages
399
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Legal Cannabis Market size was valued at US$ 68,987.67 Million in 2024, expanding at a CAGR of 13.5% from 2025 to 2032.
Cannabis can be legally authorized for medical, recreational, or industrial use, meaning it is regulated and controlled by government authorities. Medical cannabis refers to cannabis prescribed by healthcare professionals to treat specific health conditions, while recreational cannabis is legally permitted for adult use in certain regions, often with restrictions on the amount individuals can possess, cultivate, or share.
Cannabis regulations vary widely across countries and regions. For example, over 35 countries worldwide have legalized medical cannabis, including Canada, Germany, and Australia, while recreational cannabis is fully legal in countries like Canada, Uruguay, and parts of the United States. Some jurisdictions allow limited possession, home cultivation, and regulated commercial sales, whereas others permit personal use but prohibit commercial distribution, and some regions still classify cannabis as entirely illegal. Governments are increasingly implementing frameworks to control production, distribution, and quality, ensuring safety standards, reducing illicit markets, and monitoring public health impacts. These regulatory efforts are shaping global access, consumption, and commercialization of cannabis.
Legal Cannabis Market- Market Dynamics
Rising Demand for Medical Care Driving Market Growth
The global market for legal cannabis is poised for significant growth due to the rising demand for medical cannabis worldwide. According to the Mayo Clinic, medical cannabis is used to alleviate symptoms associated with a variety of health conditions. Research has shown that controlled use of medical cannabis can provide therapeutic benefits for illnesses such as amyotrophic lateral sclerosis (ALS), Crohn’s disease, glaucoma, post-traumatic stress disorder (PTSD), severe nausea or vomiting caused by cancer treatments, epilepsy, and seizures.
A report published by New Medical Life Sciences in April 2025 highlighted the long-term benefits of medicinal cannabis for individuals with chronic health conditions. Additionally, researchers at the University of Sydney found that medically supervised cannabis use improved health-related quality of life (HRQL) and was associated with reduced fatigue and fewer sleep disturbances. As the prevalence of chronic illnesses, particularly mental health disorders, continues to rise globally, there is increasing support for the regulated legalization, production, and distribution of medical cannabis under controlled conditions.
Legal Cannabis Market- Segmentation Analysis:
The worldwide market is segmented on the basis of source, derivatives, end-use, and region.
The marijuana segment continues to dominate the legal cannabis market worldwide, driven by widespread legalization and growing consumer demand. Governments in North America and Europe have led policy reforms, with over 40 countries legalizing medical cannabis and several (including parts of the U.S., Canada, Uruguay, Germany, and Luxembourg) permitting recreational use, creating a robust legal framework that fuels market expansion. Globally, the legal cannabis market is expanding rapidly, with estimates projecting the total market to reach around USD216–283billion by the early 2030s, reflecting compound annual growth as governments ease restrictions and integrate cannabis into regulated adultuse and medical systems.
This industry momentum is reflected in the strategic product launches by major producers like Aurora Cannabis Inc., which in June 2025 introduced two highTHC strains — Farm Gas and Sourdough — in Poland. Both products, grown and processed in GMPcertified facilities in Canada and Europe, are among the strongest medical cannabis flowers currently available on the Polish market, underscoring how regulatory alignment and quality standards are enabling global brands to serve regulated markets with advanced offerings.
Medical use remains the largest enduse segment in the global cannabis market, outpacing recreational applications as patients and healthcare systems increasingly adopt cannabis for therapeutic purposes. Governments and health authorities in countries such as the United States, Canada, Germany, Australia, and others have approved medical cannabis regimens for conditions ranging from chronic pain and epilepsy to chemotherapyinduced nausea, expanding legal access and supporting clinical integration. In 2025, the global medical cannabis market was valued in the tens of billions of U.S. dollars and is projected to grow strongly over the next decade, with some forecasts expecting it to exceed USD120billion by 2033.
This broad adoption is motivated by rising prevalence of chronic illnesses and supportive regulatory frameworks. For example, in the U.S., federal agencies have approved cannabisbased drugs such as Marinol and Syndros to treat chemotherapyrelated nausea, while many states continue to expand medical programs. Internationally, governmental recognition of cannabis’ therapeutic value — coupled with clear prescribing guidelines — has made medical use a key driver of legal cannabis market growth globally.
Legal Cannabis Market- Geographical Insights
North America currently dominates the legal cannabis market, driven by rising regulatory approvals and the increasing prevalence of chronic diseases. For example, according to the International Diabetes Federation (IDF) Diabetes Atlas (2025), approximately 11.1% of adults aged 20–79—about one in nine—have diabetes, with over 40% of those individuals unaware of their condition. Projections indicate that by 2050, nearly 853 million people globally will be living with diabetes, representing a 46% increase from current levels. In addition to the growing medical need, the market in North America is experiencing strong growth from both the medical and recreational cannabis segments, supported by established regulatory frameworks, widespread adoption, and increasing consumer awareness. These factors collectively reinforce the region’s position as a key driver of global cannabis market expansion.
US Legal Cannabis Market- Country Insights
The United States leads the North American cannabis market, driven by state-level legalizations, increasing medical cannabis adoption, and the diversification of product offerings, including vapes, edibles, and topicals. Medical cannabis is increasingly used to support patients with conditions such as post-traumatic stress disorder (PTSD), chronic pain, epilepsy, and anxiety. Canada, on the other hand, operates a federally legal recreational cannabis market with a well-established infrastructure for production and distribution. Its medical cannabis sector is also substantial, providing regulated access to patients in need of therapeutic support.
Globally, governments are increasingly formalizing regulations around cannabis to ensure safety, quality, and controlled access. According to the United Nations Office on Drugs and Crime (UNODC), over 35 countries have legalized medical cannabis, and more than 10 countries allow regulated recreational use, reflecting a growing trend toward governmental oversight and support for cannabis as a legal, regulated substance. These policies are shaping global market expansion by providing clear frameworks for production, distribution, and patient access while reducing illicit markets.
Legal Cannabis Market- Competitive Landscape:
The legal cannabis market is highly competitive, with both established industry leaders and rapidly growing new entrants striving to innovate, expand into new regions, and integrate all aspects of the cannabis value chain—from cultivation and extraction to retail distribution. Major players in the market include Canopy Growth Corporation, Charlotte\'s Web, Aurora Cannabis Inc., Tilray, Green Thumb Industries (GTI), Verano, Cresco Labs, The Cronos Group, Curaleaf Holdings, Trulieve Cannabis Corp., and Glass House Brands Inc. These companies differentiate themselves by offering a diverse range of products, including THC- and CBD-based edibles, beverages, topicals, and wellness products, optimizing cultivation methods, and integrating retail and delivery systems to enhance customer accessibility.
Recent Developments:
- In October 2025, CR Wellness announced an international partnership with Cookies, bringing the globally recognized cannabis brand to Brazil with the launch of premium cannabis and CBD wellness products.
- In November 2025, Nextleaf Solutions Ltd., a multi-patented Canadian life sciences and cannabis processor, launched its new national recreational brand, Yard, further expanding its presence in the recreational cannabis market.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LEGAL CANNABIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Jazz Pharmaceuticals, Inc.
- Medical Marijuana, Inc.
- Aurora Cannabis, Inc.
- Tilray Brands
- The Cronos Group
- Organigram Holding, Inc.
- Tikun Olam
- ENDOCA
- Isodiol International, Inc.
- Canopy Growth Corporation
- NuLeaf Naturals, LLC
- Maricann Inc.
- Hempstrol
- Releaf Dispensary Ltd
- Montu Group UK
GLOBAL LEGAL CANNABIS MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032
- Marijuana
- Hemp
GLOBAL LEGAL CANNABIS MARKET, BY DERIVATIVES- MARKET ANALYSIS, 2019 - 2032
- CBD
- THC
- Others
GLOBAL LEGAL CANNABIS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
- Medical Use
- Recreational Use
- Industrial Use
GLOBAL LEGAL CANNABIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Legal Cannabis Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Legal Cannabis Market Snippet by Source
2.1.2. Legal Cannabis Market Snippet by Derivative
2.1.3. Legal Cannabis Market Snippet by End-Use
2.1.4. Legal Cannabis Market Snippet by Country
2.1.5. Legal Cannabis Market Snippet by Region
2.2. Competitive Insights
3. Legal Cannabis Key Market Trends
3.1. Legal Cannabis Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Legal Cannabis Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Legal Cannabis Market Opportunities
3.4. Legal Cannabis Market Future Trends
4. Legal Cannabis Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Legal Cannabis Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Legal Cannabis Market Landscape
6.1. Legal Cannabis Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Legal Cannabis Market – By Source
7.1. Overview
7.1.1. Segment Share Analysis, By Source, 2024&2032 (%)
7.1.2. Marijuana
7.1.3. Hemp
8. Legal Cannabis Market – By Derivative
8.1. Overview
8.1.1. Segment Share Analysis, By Derivative, 2024&2032 (%)
8.1.2. CBD
8.1.3. THC
8.1.4. Others
9. Legal Cannabis Market – By End-Use
9.1. Overview
9.1.1. Segment Share Analysis, By End-Use, 2024&2032 (%)
9.1.2. Medical Use
9.1.3. Recreational Use
9.1.4. Industrial Use
10. Legal Cannabis Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Legal Cannabis Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.2.4. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.2.5. North America Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.7.3. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.2.7.4. U.S. Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.8.3. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.2.8.4. Canada Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3. Europe
10.3.1. Overview
10.3.2. Legal Cannabis Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.3.4. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.5. Europe Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.7.3. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.7.4. Germany Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.8.3. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.8.4. UK Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.9.3. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.9.4. France Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.10.3. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.10.4. Italy Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.11.3. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.11.4. Spain Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.12.3. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.12.4. The Netherlands Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.13.3. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.13.4. Sweden Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.14.3. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.14.4. Russia Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.15.3. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.15.4. Poland Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Legal CannabisKey Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.4.4. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.4.5. APAC Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.7.3. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.4.7.4. China Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.8.3. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.4.8.4. India Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.9.3. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.4.9.4. Japan Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.10.3. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.4.10.4. South Korea Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.11.3. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.4.11.4. Australia Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.12.3. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.4.12.4. Indonesia Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.13.3. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.4.13.4. Thailand Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.14.3. PhilippinesMarket Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.4.14.4. Philippines Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.15.3. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.4.15.4. Rest of APAC Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Legal Cannabis Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.5.4. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.5.5. LATAM Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.7.3. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.5.7.4. Brazil Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.8.3. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.5.8.4. Mexico Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.9.3. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.5.9.4. Argentina Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.10.3. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.5.10.4. Colombia Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Legal CannabisKey Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.6.4. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.6.5. MEA Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.8.3. UAE Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.6.8.4. UAE Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.9.3. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.6.9.4. Israel Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.10.3. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.6.10.4. Turkey Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.11.3. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.6.11.4. Algeria Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.12.3. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.6.12.4. Egypt Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.13.3. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Billion)
10.6.13.4. Rest of MEA Market Size and Forecast, By Derivative, 2019 - 2032 (US$ Billion)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Billion)
11. Key Vendor Analysis- Legal Cannabis Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Jazz Pharmaceuticals, Inc.
11.2.2. Medical Marijuana, Inc.
11.2.3. Aurora Cannabis, Inc.
11.2.4. Tilray Brands
11.2.5. The Cronos Group
11.2.6. Organigram Holding, Inc.
11.2.7. Tikun Olam
11.2.8. ENDOCA
11.2.9. Isodiol International, Inc.
11.2.10. Canopy Growth Corporation
11.2.11. NuLeaf Naturals, LLC
11.2.12. Maricann Inc.
11.2.13. Hempstrol
11.2.14. Releaf Dispensary Ltd
11.2.15. Montu Group UK
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LEGAL CANNABIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Jazz Pharmaceuticals, Inc.
- Medical Marijuana, Inc.
- Aurora Cannabis, Inc.
- Tilray Brands
- The Cronos Group
- Organigram Holding, Inc.
- Tikun Olam
- ENDOCA
- Isodiol International, Inc.
- Canopy Growth Corporation
- NuLeaf Naturals, LLC
- Maricann Inc.
- Hempstrol
- Releaf Dispensary Ltd
- Montu Group UK
GLOBAL LEGAL CANNABIS MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032
- Marijuana
- Hemp
GLOBAL LEGAL CANNABIS MARKET, BY DERIVATIVES- MARKET ANALYSIS, 2019 - 2032
- CBD
- THC
- Others
GLOBAL LEGAL CANNABIS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
- Medical Use
- Recreational Use
- Industrial Use
GLOBAL LEGAL CANNABIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
